Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$434.0K
12.29K shares
What this filing means
HEERMA PETER plans to sell 12.29K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $434.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001193125-26-036557
Officer· Chief Commercial Officer
Since Oct 2019
12.29K
Shares to sell
$434.0K
Approx. market value
7.31K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
1/31/2026
7.31KTotal acquired7.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Unit Vesting Compensation | 7.31K | — |
| Total | 7.31K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.98K
Market value
$199.2K
12/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.31K
Market value
$234.8K
2/3/2026
Total
Units
12.29K
Value
$434.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/24/2025 | 4.98K | $199.2K | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 7.31K | $234.8K | NASDAQ | Planned |
| Total | 12.29K | $434.0K | ||